• Your shopping cart is empty!

PDF Preview

CLSI C43-A2

Gas Chromatography/Mass Spectrometry Confirmation of Drugs; Approved Guideline-Second Edition, C43A2E

Clinical and Laboratory Standards Institute, 03/01/2010

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/03/2010

File Size:1 file , 2 MB

Note:This product is unavailable in Russia, Belarus

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI's library.

This document provides guidance on establishing uniform practices necessary to produce quality data for quantitation and identification of a drug or drug metabolite using the gas chromatography/mass spectrometry method. Specific quality assurance criteria for maintaining and documenting optimal instrument performance are also presented.

More CLSI standard pdf

CLSI I/LA02-A2

CLSI I/LA02-A2

Quality Assurance of Laboratory Tests for Autoantibodies to Nuclear Antigens: (1) Indirect Fluorescence Assay for Microscopy and (2) Microtiter Enzyme Immunoassay Methods; Approved Guideline, I/LA02A2E

$123.00 $247.71

CLSI GP02A5

CLSI GP02A5

Clinical Laboratory Technical Procedure Manuals; Approved Guideline, GP02-A5

$135.00 $271.52

CLSI AUTO09-A

CLSI AUTO09-A

Remote Access to Clinical Laboratory Diagnostic Devices via the Internet; Approved Standard, AUTO09AE

$136.00 $273.14

CLSI MM10-A

CLSI MM10-A

Genotyping for Infectious Diseases: Identification and Characterization; Approved Guideline, MM10AE

$146.00 $292.03